- Home
- MRNA vs CSL Comparison
MRNA vs CSL Comparison
Compare MRNA & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- CSL
- Stock Information
- Founded
- MRNA 2010
- CSL 1917
- Country
- MRNA United States
- CSL United States
- Employees
- MRNA N/A
- CSL N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- CSL Specialty Chemicals
- Sector
- MRNA Health Care
- CSL Industrials
- Exchange
- MRNA Nasdaq
- CSL Nasdaq
- Market Cap
- MRNA 13.4B
- CSL 15.9B
- IPO Year
- MRNA 2018
- CSL N/A
- Fundamental
- Price
- MRNA $28.02
- CSL $381.68
- Analyst Decision
- MRNA Hold
- CSL Buy
- Analyst Count
- MRNA 20
- CSL 6
- Target Price
- MRNA $46.24
- CSL $450.83
- AVG Volume (30 Days)
- MRNA 8.6M
- CSL 524.6K
- Earning Date
- MRNA 08-01-2025
- CSL 07-30-2025
- Dividend Yield
- MRNA N/A
- CSL 1.05%
- EPS Growth
- MRNA N/A
- CSL N/A
- EPS
- MRNA N/A
- CSL 17.89
- Revenue
- MRNA $3,078,000,000.00
- CSL $5,001,800,000.00
- Revenue This Year
- MRNA N/A
- CSL $5.06
- Revenue Next Year
- MRNA $10.04
- CSL $5.19
- P/E Ratio
- MRNA N/A
- CSL $21.37
- Revenue Growth
- MRNA N/A
- CSL 1.37
- 52 Week Low
- MRNA $23.15
- CSL $311.41
- 52 Week High
- MRNA $91.99
- CSL $481.26
- Technical
- Relative Strength Index (RSI)
- MRNA 46.33
- CSL 48.15
- Support Level
- MRNA $25.30
- CSL $352.62
- Resistance Level
- MRNA $27.08
- CSL $400.14
- Average True Range (ATR)
- MRNA 1.33
- CSL 12.55
- MACD
- MRNA -0.31
- CSL 0.71
- Stochastic Oscillator
- MRNA 32.38
- CSL 43.30
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CSL Carlisle Companies Incorporated
Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.